QUIDEL CARDIOVASCULAR INC. – Trademark Portfolio
Entity Type: 03
QUIDEL CARDIOVASCULAR INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include TRIAGE, METERPRO, TRIAGETRUE, and TRIAGE CENSUS. The owner is based in San Diego, CA.
9975 Summers Ridge Road
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
QUIDEL CARDIOVASCULAR INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does QUIDEL CARDIOVASCULAR INC. have?
QUIDEL CARDIOVASCULAR INC. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does QUIDEL CARDIOVASCULAR INC. file in?
QUIDEL CARDIOVASCULAR INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are QUIDEL CARDIOVASCULAR INC.'s most well-known trademarks?
QUIDEL CARDIOVASCULAR INC.'s registered trademark portfolio includes well-known marks such as TRIAGE, METERPRO, TRIAGETRUE, and TRIAGE CENSUS. These are among 6 currently registered trademarks in the portfolio.
What is QUIDEL CARDIOVASCULAR INC.'s trademark registration success rate?
QUIDEL CARDIOVASCULAR INC. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.